Allergan's Abicipar Effective With Fewer Injections, But More Inflammation In AMD

Close-up of blue eye. High Technologies in the futuristic. : cataract
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D